Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphate (APD).

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Breast Cancer Research and Treatment

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8369528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): Respective role of kidney and bone

  1990cited by this paper
• Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP.

  1988cited by this paper
• Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia.

  1988cited by this paper
• Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy

  1988cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper

• Common acute oncological emergencies: diagnosis, investigation and management

  2008cites this paper
• Hypercalcemia in patients with breast cancer: a survival study

  2005cites this paper
• Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells.

  2001cites this paper
• Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines.

  2000cites this paper
• The management of bone metastases.

  2000cites this paper
• Effects of alendronate on bone metastases and hypercalcemia after surgery for hepatocellular carcinoma.

  2000cites this paper
• Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia

  1998cites this paper
• Parathyroid hormone‐related protein and bone metastases

  1997cites this paper